MUSTANG BIO, INC. Operating Income Loss

Quick Answer

MUSTANG BIO, INC. reported Operating Income Loss of -$2.43 million for the year ending 2025.

  • MUSTANG BIO, INC. showed an increase of +85.0% in Operating Income Loss from 2024 to 2025.
  • This data is from MUSTANG BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2015: -$537.0 thousand | Q3 2015: -$658.0 thousand | Q4 2015: -$843.0 thousand | Q1 2016: -$822.0 thousand | Q2 2016: -$1.04 million | Q3 2016: -$1.67 million | Q4 2016: -$7.83 million | Q1 2017: -$3.31 million | Q2 2017: -$5.67 million | Q3 2017: -$7.08 million | Q4 2017: -$15.73 million | Q1 2018: -$6.48 million | Q2 2018: -$5.24 million | Q3 2018: -$7.66 million | Q4 2018: -$11.85 million | Q1 2019: -$9.75 million | Q2 2019: -$10.21 million | Q3 2019: -$10.00 million | Q4 2019: -$15.92 million | Q1 2020: -$11.52 million | Q2 2020: -$14.12 million | Q3 2020: -$10.43 million | Q1 2021: -$15.09 million | Q2 2021: -$14.44 million | Q3 2021: -$17.08 million | Q1 2022: -$19.64 million | Q2 2022: -$18.24 million | Q3 2022: -$18.85 million | Q1 2023: -$16.32 million | Q2 2023: -$13.89 million | Q3 2023: -$10.31 million | Q1 2024: -$5.23 million | Q2 2024: -$8.54 million | Q3 2024: -$1.46 million | Q1 2025: -$253.0 thousand | Q2 2025: -$885.0 thousand | Q3 2025: -$624.0 thousand.
  • Over the full 11 years of available data (2015 to 2025), MUSTANG BIO, INC.'s Operating Income Loss has declined by 7.6%.
  • Historical annual values: Fiscal year 2025: -$2.43 million | Fiscal year 2024: -$16.25 million | Fiscal year 2023: -$49.26 million | Fiscal year 2022: -$76.16 million | Fiscal year 2021: -$66.72 million | Fiscal year 2020: -$56.81 million | Fiscal year 2019: -$45.89 million | Fiscal year 2018: -$31.22 million | Fiscal year 2017: -$31.79 million | Fiscal year 2016: -$11.36 million | Fiscal year 2015: -$2.26 million.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: